医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Bruker Opens Two New Centers of Excellence in Mumbai and Bengaluru

2013年02月28日 AM12:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Dr. Frank Laukien, Bruker’s President and CEO and Dr. Shreeram Oak, Country Manager of Bruker Optics India during the opening ceremony “Deep Prajvalan” (“Lighting of the Lamp”).
(Photo: Business Wire)

View and Share Photo

Close Window


MUMBAI & BENGALURU, India

Bruker, a leading provider of high-performance scientific instruments for molecular and materials research, as well as for industrial, clinical and applied analysis, celebrates the grand openings of its new Mumbai and Bengaluru Centers of Excellence (CoE) this week. For over three decades, Bruker has grown its presence in India, with sales and service capabilities in most major cities in India, including New Delhi, Mumbai, Bengaluru, Chennai, Kolkata, Lucknow and Hyderabad, as well as several other Indian cities. This year, Bruker is expecting approximately $50 million in revenue in India, employing over 100 staff, complemented by several high-quality distributors with service capabilities for some of Bruker’s product lines.

Dr. Frank Laukien, Bruker's President and CEO and Dr. Shreeram Oak, Country Manager of Bruker Optics ...

Dr. Frank Laukien, Bruker’s President and CEO and Dr. Shreeram Oak, Country Manager of Bruker Optics India during the opening ceremony “Deep Prajvalan” (“Lighting of the Lamp”).
(Photo: Business Wire)

Bruker’s new Centers of Excellence in Mumbai and Bengaluru now offer a new, even higher level of customer support in the important and growing Indian markets for scientific and analytical instrumentation. Bringing together a wide range of Bruker divisional operations in India, the new CoE facilities offer our customers access to multi-technology applications, training and demonstration capabilities. These Centers of Excellence will also aim to support research collaborations between Bruker and key customers in India. Their locations were chosen for their proximity to major academic, government and industrial research laboratories, and also to major hubs for the strong Indian pharma, biotechnology and CRO industry, as well as to major clinical research centers, and to important centers for the cement, metals, manufacturing, food and other industries.

Dr. Frank Laukien, Bruker’s President and CEO, commented: “With this significant investment in our two new Centers of Excellence, Bruker has taken a major step forward in India to provide highest-level support for the outstanding and rapidly growing Indian research, industrial and clinical communities.”

Bruker, a leading provider of high-performance scientific instruments and solutions for molecular and materials research as well as for industrial, clinical and applied analysis, has long been committed to India. Its long-standing presence in and support for the Indian research community began with initial NMR anf FT-IR installations almost 40 years ago. Bruker is a market and technology leader in many fields, including magnetic resonance (NMR, preclinical MRI, EPR), atomic force microscopy (AFM), stylus and optical metrology, EDS and EBSD accessories for 3rd party electron microscopes, X-ray diffraction and crystallography, X-ray and spark-OES elemental analysis, life-science, clinical and applied market chromatography and mass spectrometry, as well as infrared and Raman spectroscopy.

About Bruker Corporation

Bruker Corporation (NASDAQ: BRKR) is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. For more information, please visit www.bruker.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130227005962/en/

CONTACT

Media Contact for Bruker Corporation
Dr. Thorsten Thiel, +49
(721) 5161 – 6500
Bruker Director of Marketing Communications
thorsten.thiel@bruker.com

同じカテゴリーの記事 

  • ルベド・ライフ・サイエンシズとバイヤスドルフ、細胞老化に対する新たなスキンケア製品の開発で複数年にわたるパートナーシップを発表
  • Atom Bioscience Enrolling Patients in US as Part of a Global Phase 2b/3 Clinical Trial of a New Investigational Treatment for Chronic Gout
  • Rubedo Life Sciences和Beiersdorf宣布建立多年合作伙伴关系,共同开发解决细胞衰老问题的护肤新品
  • 日本天皇陛下和皇后出席2024年度日本奖颁奖典礼
  • Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions